Search
for
Sort by
Research 19
- Sudden Akathisia After a Ziprasidone Dose Reduction
- Adverse Cutaneous Reactions to Antipsychotics
- Treatment of Delusional Infestation with Olanzapine
- Psychodermatology
- Obsessive-compulsive disorder in dermatology
- Adverse cutaneous effects of psychotropic medications
- Severe hair loss associated with psyc hotropic drugs in psychiatric inpatients—Data from an observational pharmacovigilance program in German-speaking countries
- Update on psychodermatological disorders
- Psychotropic Treatment of Psychodermatologic Disorders
- Debatable Topics in PCOS Patients
- Chemically Induced Hair Loss/Alopecia
- Impact of the Different Preparation Methods to Obtain Human Adipose-Derived Stromal Vascular Fraction Cells (AD-SVFs) and Human Adipose-Derived Mesenchymal Stem Cells (AD-MSCs): Enzymatic Digestion Versus Mechanical Centrifugation
- Psychological interventions in the management of common skin conditions
- Self-Emulsifying Drug Delivery Systems (SEDDS): Measuring Energy Dynamics to Determine Thermodynamic and Kinetic Stability
- Bipolar Patients and Bullous Pemphigoid after Risperidone Long-Acting Injectable: A Case Report and a Review of the Literature
- Hirsutism in a Female Adolescent Induced by Long-Acting Injectable Risperidone
- Patterns of psychotropic medication prescribing and potential drug-hormone interactions among transgender and gender-diverse adults within 2 years of hormone therapy
- Identification of xenobiotics interfering with 5 <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" display="inline" id="d1e152" altimg="si21.svg"> <mml:mi>α</mml:mi> </mml:math> -reductase (SRD5A2) activity
- ZALCITABINE